There will be some small revenue in 2021 from Rett - small possibility Enter 2022 and I can see revenue from PDD and Rett with some contribution from AZ
From 2022 forward - revenue will grow exponentionaly and share price would be north of 150
Lets worry about this later
Execution on trials right now is more important...hopefully all goes to plan